On November 14, 2019, Research Infosource released its 2019 rankings of Canada’s top 40 research hospitals. Once again, CAMH was listed as the number one mental health research hospital in the country, as well as one of Canada’s top-ranked research-intensive hospitals overall.
“The fact that our research program continues to grow, and is now such a significant part of our hospital's overall activity, is something of which everyone should be proud,” said Bruce Pollock, Vice President of Research and Director of the Campbell Family Mental Health Research Institute at CAMH. “We know mental illness is the leading cause of disability in Canada, and that one in five Canadians will experience a mental illness including addiction in any given year. The research we undertake at CAMH is crucial to improving health outcomes now and into the future.”
CAMH is home to world-class research ranging from innovations in personalized medicine, to brain stimulation, to geriatric mental health, and more. As one of the top brain imaging centres in the world fully dedicated to brain health including addictions, the Research Imaging Centre is a global leader, giving scientists the ability to see new paths in brain chemistry structure, function and behaviour in mental illness.
The Temerty Centre for Therapeutic Brain Intervention is one of the world’s top centres in brain stimulation treatment, research and training. Through clinical research, the Temerty Centre is advancing treatment using repetitive transcranial magnetic stimulation (rTMS); magnetic seizure therapy (MST); and electroconvulsive therapy (ECT), creating tremendous hope for people with treatment-resistant depression.
The Tanenbaum Centre for Pharmacogenetics is an international pioneer in gene-guided treatment for mental illness. The Centre performs state-of-the-art research dedicated to understanding the way individual genetic profiles affect how people respond to different medications, and houses the largest set of participant DNA’s collected by any mental health institution globally.
CAMH is a global trailblazer in the fight against Alzheimer's Disease, and is leading some of the largest clinical trials that aim at the prevention of Alzheimer's.
The Krembil Centre for Neuroinformatics is taking an unprecedented approach to personalized medicine by creating brain models to make predictions about mental health using data and technology. These more precise treatments for patients can lead to better outcomes and faster recovery.
CAMH is also home to the Institute for Mental Health Policy Research which houses leading scientific experts dedicated to informing policy decisions, intervention development and health system improvement through collaborative research on communities, populations, health systems and global health.